JP2006036796A5 - - Google Patents

Download PDF

Info

Publication number
JP2006036796A5
JP2006036796A5 JP2005305080A JP2005305080A JP2006036796A5 JP 2006036796 A5 JP2006036796 A5 JP 2006036796A5 JP 2005305080 A JP2005305080 A JP 2005305080A JP 2005305080 A JP2005305080 A JP 2005305080A JP 2006036796 A5 JP2006036796 A5 JP 2006036796A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
substituted
cancer
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005305080A
Other languages
English (en)
Japanese (ja)
Other versions
JP4699171B2 (ja
JP2006036796A (ja
Filing date
Publication date
Priority claimed from US10/224,979 external-priority patent/US6800655B2/en
Application filed filed Critical
Publication of JP2006036796A publication Critical patent/JP2006036796A/ja
Publication of JP2006036796A5 publication Critical patent/JP2006036796A5/ja
Application granted granted Critical
Publication of JP4699171B2 publication Critical patent/JP4699171B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005305080A 2002-08-20 2005-10-19 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物 Expired - Fee Related JP4699171B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/224,979 2002-08-20
US10/224,979 US6800655B2 (en) 2002-08-20 2002-08-20 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004531045A Division JP4764629B2 (ja) 2002-08-20 2003-08-15 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物

Publications (3)

Publication Number Publication Date
JP2006036796A JP2006036796A (ja) 2006-02-09
JP2006036796A5 true JP2006036796A5 (OSRAM) 2006-08-10
JP4699171B2 JP4699171B2 (ja) 2011-06-08

Family

ID=31946289

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004531045A Expired - Fee Related JP4764629B2 (ja) 2002-08-20 2003-08-15 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物
JP2005305080A Expired - Fee Related JP4699171B2 (ja) 2002-08-20 2005-10-19 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物
JP2010139927A Expired - Fee Related JP5599236B2 (ja) 2002-08-20 2010-06-18 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004531045A Expired - Fee Related JP4764629B2 (ja) 2002-08-20 2003-08-15 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010139927A Expired - Fee Related JP5599236B2 (ja) 2002-08-20 2010-06-18 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物

Country Status (8)

Country Link
US (4) US6800655B2 (OSRAM)
EP (2) EP1623985B1 (OSRAM)
JP (3) JP4764629B2 (OSRAM)
AT (1) ATE411317T1 (OSRAM)
AU (1) AU2003263878A1 (OSRAM)
CA (1) CA2496203C (OSRAM)
DE (1) DE60324155D1 (OSRAM)
WO (1) WO2004018475A2 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
US8080577B2 (en) * 2004-05-06 2011-12-20 Bioresponse, L.L.C. Diindolylmethane formulations for the treatment of leiomyomas
US20060100264A1 (en) * 2004-11-06 2006-05-11 Bjeldanes Leonard F 3,3'-Diindolylmethane immune activating compositions
CA2593084C (en) * 2004-12-30 2014-03-18 Bioresponse, Llc Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
WO2006077424A1 (en) 2005-01-21 2006-07-27 Astex Therapeutics Limited Pharmaceutical compounds
AU2006251832A1 (en) * 2005-05-27 2006-11-30 Queen's University At Kingston Treatment of protein folding disorders
CN1807413B (zh) * 2005-09-28 2010-05-05 中国医学科学院医药生物技术研究所 咔唑磺酰胺衍生物及其制备方法
AU2007239283B2 (en) 2006-04-18 2013-02-07 Nippon Chemiphar Co., Ltd. Activating agent for peroxisome proliferator activated receptor delta
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
BRPI0717753B1 (pt) 2006-10-27 2022-04-12 Bioresponse, Llc Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição
US7807705B2 (en) * 2007-05-18 2010-10-05 The Ohio State University Research Foundation Potent indole-3-carbinol-derived antitumor agents
US20100292316A1 (en) * 2007-07-18 2010-11-18 Research Development Foundation Improved therapeutic methods and compositions comprising chroman ring compounds
TWI440633B (zh) * 2008-04-15 2014-06-11 Nippon Chemiphar Co Activator of Activated Receptors for Peroxisome Producers
WO2010033198A2 (en) * 2008-09-17 2010-03-25 Sri International Analogs of indole-3-carbinol and their use as agents against infection
KR101477613B1 (ko) * 2009-03-31 2014-12-30 롬엔드하스전자재료코리아유한회사 신규한 유기 전자재료용 화합물 및 이를 포함하는 유기 전자 소자
WO2010118339A2 (en) * 2009-04-09 2010-10-14 University Of Kansas Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
EP2464349A2 (en) * 2009-08-14 2012-06-20 Cerenis Therapeutics S.A. Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases
US8153680B2 (en) * 2009-08-25 2012-04-10 The Ohio State University Research Foundation Alkyl indole-3-carbinol-derived antitumor agents
DE102009052428A1 (de) * 2009-11-10 2011-05-12 Merck Patent Gmbh Verbindung für elektronische Vorrichtungen
AU2011248175A1 (en) * 2010-05-06 2012-10-25 Merck Sharp & Dohme Corp. Aza-Indole derivatives useful as modulators of FAAH
AU2012236807B2 (en) * 2011-04-01 2016-10-27 Sri International Lipoxygenase inhibitors
WO2015042170A1 (en) 2013-09-17 2015-03-26 Wayne State University Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
CN104030964B (zh) * 2014-06-05 2016-06-29 天津科技大学 双吲哚类化合物及合成方法
US9969686B2 (en) * 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
AU2016245984B2 (en) 2015-04-10 2021-03-25 Bioresponse, L.L.C. Self-emulsifying formulations of DIM-related indoles
WO2017011920A1 (en) * 2015-07-22 2017-01-26 The Royal Institution For The Advancement Of Learning/Mcgill University Compounds and uses thereof in the treatment of cancers and other medical conditions
CN105218552B (zh) * 2015-09-30 2018-02-27 中国人民解放军军事医学科学院野战输血研究所 一种取代苯基二氢吲哚咔唑衍生物及其制备方法与应用
CN110698654B (zh) * 2018-07-10 2021-04-02 中国科学院长春应用化学研究所 基于三聚吲哚的超支化共轭聚电解质及其制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1282451B (de) * 1965-09-01 1968-11-07 Kalle Ag Lichtempfindliche Schicht und Verfahren zur Herstellung fixierter Bilder
US4636820A (en) * 1980-03-06 1987-01-13 The Hilton-Davis Chemical Compositions, process and systems
DE3752344D1 (de) * 1986-10-28 2002-01-17 Ciba Sc Holding Ag Chromogene Phthalide
GB8713564D0 (en) 1987-06-10 1987-07-15 Kong Y C Synthesis
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US5116978A (en) * 1989-03-08 1992-05-26 Appleton Papers Inc. Process for bis(indolyl)ethylene synthesis
US5086171A (en) * 1989-03-08 1992-02-04 Appleton Papers Inc. Bis-(indolyl)ethylenes
JP3038064B2 (ja) * 1991-10-07 2000-05-08 日清製粉株式会社 インドール誘導体およびこれを有効成分とする抗潰瘍薬
EP0540468B1 (de) * 1991-10-30 1996-12-04 Ciba-Geigy Ag NIR-Farbstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung
US5206377A (en) * 1991-12-05 1993-04-27 Whitby Research, Inc. Compounds useful as antiproliferative agents
US5407102A (en) * 1994-02-15 1995-04-18 Freudinger; Mark J. Apparatus for dispensing a quantity of flowable material
US5948808A (en) * 1997-03-07 1999-09-07 The Texas A&M University System Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
US5942340A (en) * 1997-10-02 1999-08-24 Xerox Corporation Indolocarbazole electroluminescent devices
US5843607A (en) * 1997-10-02 1998-12-01 Xerox Corporation Indolocarbazole photoconductors
ATE230394T1 (de) 1998-05-04 2003-01-15 Zentaris Ag Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
ATE277010T1 (de) * 1998-07-08 2004-10-15 Harbor Branch Oceanographic Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
IT1317926B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
IT1317925B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Bis-eterocicli ad attivita' antitumorale e chemosensibilizzante.
JP2003346530A (ja) * 2002-05-23 2003-12-05 Nippon Sheet Glass Co Ltd 面状光源装置および画像読み取り装置
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

Similar Documents

Publication Publication Date Title
JP2006036796A5 (OSRAM)
JP2006500379A5 (OSRAM)
CA2496203A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
ES2394472T3 (es) Derivados de quinazolín-oxima como inhibidores de hsp90
ES2487534T3 (es) Derivados de 2,4 di[(hetero)-arilamino]-pirimidina como inhibidores de Zap-70 y/o SYK
US7166595B2 (en) Compounds, methods and compositions
CN111808136B (zh) 核苷酸类似物
JP2009502809A5 (OSRAM)
JP5607241B2 (ja) 新規ピリミジン誘導体
EP2173724A2 (en) Quinazolinone compounds and methods of use thereof
JPH0597813A (ja) アンギオテンシンｉｉ拮抗剤としての酸性官能基を有するイミダゾール誘導体
JP2022549923A (ja) Ｎヘテロ五員環含有カプシドタンパク質集合阻害剤の結晶形及びその使用
US20060004073A1 (en) Compounds, compositions, and methods
CN101468985A (zh) 5-(3-芳杂环取代苯基)四氮唑类化合物及其抗hiv/aids的应用
JPH0625232A (ja) 置換インドールおよびベンズイミダゾール誘導体
CN101511354A (zh) 联苯基取代的螺季酮酸和它们用于治疗逆转录病毒疾病的应用
CN101314584A (zh) HGF/c-Met信号通道抑制剂及其制备方法和用途
CN104684913B (zh) 三(杂)芳基吡唑及其应用
CN110724140A (zh) 二氢喹嗪酮羧酸类化合物及其应用
WO2007074940A1 (ja) Ｐ２ｘ４受容体拮抗剤
CN112351971B (zh) 喹啉或喹唑啉类化合物及其应用
CN101759720B (zh) 一种开环核苷膦化物类化合物或其药用盐、其制备方法、应用、中间体及含其的药物组合物
CN1081442A (zh) 苯并二氮杂䓬
WO2006106721A1 (ja) チロシンキナーゼ阻害作用を有するピリミジン誘導体
Giang et al. Design, synthesis and cytotoxic evaluation of 4-anilinoquinazoline–triazole–azt hybrids as anticancer agents